Teladoc Health, Inc. Q3 2026 Earnings Recap

TDOC Q3 2026 Published October 30, 2026

Get alerts when TDOC reports next quarter

Teladoc shares surged 26.9% after Q3 revenue came in near the upper end of guidance and adjusted EBITDA exceeded guidance. BetterHelp also performed toward the high end of its revenue range, though management expects cash-pay challenges to continue.

Earnings Per Share Beat

$-0.15 vs $-0.22 est.

+31.0% surprise

Revenue Beat

605102000 vs 588137300 est.

+2.9% surprise

Market Reaction

Post-Earnings +26.89%

Oct 30 to Nov 6 +3.06%

See TDOC alongside your other holdings

Add to your portfolio — free

Key Takeaways

Consolidated revenue was near the upper end of guidance; adjusted EBITDA was above guidance.
Integrated Care revenue was near the high end of guidance, with adjusted EBITDA margin above guidance.
BetterHelp revenue was in the upper end of guidance, supported by insurance growth and better-than-anticipated cash-pay performance; management still expects ongoing cash-pay challenges.
Teladoc began activating initial launch partners for Teladoc 1 and is preparing for broader market availability in 2027.
The company completed an acquisition of a business serving U.S. hospitals and health systems, expanding its virtual-care services in that market.

This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit TDOC on AllInvestView.

Previous Q2 2026